Monday, June 15, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 949 of 1,261
  1. US 8034946

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted
  2. US 8034950

    Processes for the facile synthesis of diaryl amines and analogues thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted
  3. US 8034832

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted
  4. DE 202010004750

    Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut

    BIOFRONTERA BIOSCIENCE GMBH [DE] · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted
  5. CA 2790257

    CANULE D'IMPLANT COMPORTANT UN IMPLANT ET PROCEDE DE FIXATION D'IMPLANTS DANS UNE CANULE D'INJECTION

    ACINO AG [DE] · Granted Oct 6, 2011 · Expires Oct 1, 2031

    granted
  6. US 8030070

    Artificial lymphoid tissue equivalent

    SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  7. US 8030280

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  8. US 8030488

    Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  9. US 8029804

    Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

    United States of America as represented by the Secretary of the Air Force · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  10. US 8029791

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  11. US 8029809

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  12. US 8029808

    Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

    UNIVERSITY OF CONNECTICUT · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  13. US 8030445

    Glycopeptide derivative

    Theravance, Inc. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  14. US 8030285

    Oligodeoxynucleotide and its use to induce an immune response

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  15. US 8030074

    In vivo incorporation of unnatural amino acids

    The Regents of the University of California · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  16. US 8030012

    Id-1 and Id-2 genes and products as markers of epithelial cancer

    The Regents of the University of California · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  17. US 8030010

    Method for detecting a biomarker of oxidative stress in a biological sample

    INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  18. US 8030493

    Monovalent and divalent salts of N-(5-hydroxynicotinoil) -L-glutamic acid exhibiting psychotropic (antidepressant and anxiolytic), neuroprotective, geroprotective and cerebroprotective action

    Obschestvo S Ogranichennoy Otvetstvennostyu “Natsionalnaya Isseldovatelskaya Kompaniya” · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  19. US 8030307

    Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease

    Enanta Pharmaceuticals, Inc. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  20. US 8030333

    Benzimidazole compound crystal

    Takeda Pharmaceutical Company Limited · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  21. US 8030317

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  22. US 8030331

    Allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  23. US 8030341

    Dmt-derivative compounds and related compositions and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  24. US 8030337

    Tricyclic compound and pharmaceutical use thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.